Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27 KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines

Author: Shintani S.   Li C.   Mihara M.   Yano J.   Terakado N.   Nakashiro K.-i.   Hamakawa H.  

Publisher: Elsevier

ISSN: 1368-8375

Source: Oral Oncology, Vol.40, Iss.1, 2004-01, pp. : 43-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content